Inventor
AMY JOHNSON
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07KPeptides14%
C12NMicroorganisms or enzymes14%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture14%
C12YEnzymes14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
PatentTitleYear
12,012,445Anti-VEGF protein compositions and methods for producing the same202411,732,025Anti-VEGF protein compositions and methods for producing the same202311,548,932Anti-VEGF protein compositions and methods for producing the same202311,535,663Methods for producing aflibercept in chemically defined media having reduced aflibercept variants202211,505,594Anti-VEGF protein compositions and methods for producing the same202211,472,861Methods for producing aflibercept in chemically defined media having reduced aflibercept variants2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to REGENERON PHARMA (6)· patent assignee history
2022–2023Patents assigned to REGENERAN PHARMACEUTICALS INC (2)· patent assignee history
2022–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 6 | 2022–2024 |
| REGENERAN PHARMACEUTICALS INC | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2024 |